Cargando…
NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis
BACKGROUND: Warfarin has been the anticoagulant of choice for the prevention of ischaemic stroke in patients with atrial fibrillation (AF). Novel oral anticoagulants (NOACs) are increasingly used as an alternative. OBJECTIVES: The objective of this review was to evaluate the efficacy and safety of t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731839/ https://www.ncbi.nlm.nih.gov/pubmed/26848392 http://dx.doi.org/10.1136/openhrt-2015-000279 |